Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Designed to increase throughput, decrease COGS, and reduce batch failures.
January 17, 2025
By: Kristin Brooks
Managing Editor, Contract Pharma
Oribiotech Ltd., a provider of cell and gene therapy (CGT) manufacturing technology, announces the first customer deliveries of the new IRO platform, specifically designed to help address the current challenges in CGT manufacturing. In December 2024, four IRO instruments were delivered to multiple contract development and manufacturing organizations (CDMOs) and a global pharmaceutical company.
Through its Lightspeed Early Access Program which generates data with partners, IRO has proven to automate better biology and address critical manufacturing bottlenecks to dramatically increase throughput, decrease COGS, and reduce batch failures, according to the company. By reducing labor requirements by up to 70%, reducing the cost of goods by up to 50%, cutting processing times by up to 25%, and accelerating tech transfer times from months to weeks, the IRO platform aims to advance therapy development timelines.
IRO has the flexibility needed for early R&D and the ability to scale into GMP manufacturing with the same instrument, consumables, and process for a seamless transition from R&D to GMP. By automating, digitizing, and standardizing the most time-consuming and labor-intensive parts of the cell and gene therapy manufacturing workflow, IRO aims to allow scientists to quickly optimize their processes.
“Research and development teams no longer have to sacrifice biological performance to gain the benefits of automation – IRO delivers both,” said Farlan Veraitch, PhD, CSO and Founder of Ori Biotech. “IRO offers the flexibility needed for R&D while maintaining the precision and control essential for GMP manufacturing. We’re excited that this technology is now in the hands of partners who will harness its potential to drive meaningful clinical impact for patients.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !